{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:42:28Z","timestamp":1792978948624,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.ijpharm.2018.04.032","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T13:22:36Z","timestamp":1523971356000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization"],"prefix":"10.1016","volume":"544","author":[{"given":"Daniela E.","family":"Igart\u00faa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina S.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Facundo","family":"Temprana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia del V.","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Jimena","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.04.032_b0005","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/bs.podrm.2015.11.001","article-title":"Chapter three-carbamazepine","volume":"41","author":"Alrashood","year":"2016","journal-title":"Profiles Drug Subst. Excipients Related Methodol."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.04.032_b0010","doi-asserted-by":"crossref","first-page":"E536","DOI":"10.1208\/pt060367","article-title":"Poly (amidoamine)(PAMAM) dendritic nanostructures for controlled sitespecific delivery of acidic anti-inflammatory active ingredient","volume":"6","author":"Asthana","year":"2005","journal-title":"AAPS PharmSciTech"},{"issue":"22","key":"10.1016\/j.ijpharm.2018.04.032_b0015","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1016\/S0040-4020(03)00437-X","article-title":"Dendrimers as potential drug carriers; encapsulation of acidic hydrophobes within water soluble PAMAM derivatives","volume":"59","author":"Beezer","year":"2003","journal-title":"Tetrahedron"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0020","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.vascn.2008.05.130","article-title":"Zebrafish based assays for the assessment of cardiac, visual and gut function \u2014 potential safety screens for early drug discovery","volume":"58","author":"Berghmans","year":"2008","journal-title":"J. Pharmacol. Toxicol. Methods"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0025","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0378-5173(03)00132-7","article-title":"A PEGylated dendritic nanoparticulate carrier of fluorouracil","volume":"257","author":"Bhadra","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.ijpharm.2018.04.032_b0030","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol. Lett."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.04.032_b0035","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/jps.2600800420","article-title":"Development of aqueous parenteral formulations for carbamazepine through the use of modified cyclodextrins","volume":"80","author":"Brewster","year":"1990","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0040","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2017.00170","article-title":"Autophagy and its impact on neurodegenerative diseases: new roles for TDP-43 and C9orf72","volume":"10","author":"Budini","year":"2017","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2017.10.003","article-title":"Nanotoxicological and teratogenic effects: A linkage between dendrimer surface charge and zebrafish developmental stages","author":"Calienni","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"15","key":"10.1016\/j.ijpharm.2018.04.032_b0050","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.addr.2005.09.012","article-title":"Dendrimer\u2013drug interactions","volume":"57","author":"Demanuele","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0055","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijpharm.2007.05.039","article-title":"Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes","volume":"345","author":"Devarakonda","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"15","key":"10.1016\/j.ijpharm.2018.04.032_b0060","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.addr.2005.09.019","article-title":"Dendrimer biocompatibility and toxicity","volume":"57","author":"Duncan","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0378-5173(98)00093-3","article-title":"Enhancement of carbamazepine dissolution: in vitro and in vivo evaluation","volume":"168","author":"El-Zein","year":"1998","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0070","first-page":"1","article-title":"Nutraceutical emulsion containing valproic acid (NE-VPA): a drug delivery system for reversion of seizures in zebrafish larvae epilepsy model","author":"Feas","year":"2017","journal-title":"J. Pharm. Investig."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0075","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.toxlet.2005.07.001","article-title":"In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride","volume":"160","author":"Fotakis","year":"2006","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0080","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3109\/08982104.2010.491073","article-title":"Relationship between the adjuvant and cytotoxic effects of the positive charges and polymerization in liposomes","volume":"21","author":"Gasparri","year":"2011","journal-title":"J. Liposome Res."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0085","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijpharm.2005.09.013","article-title":"Nasal administration of carbamazepine using chitosan microspheres: in vitro\/in vivo studies","volume":"307","author":"Gavini","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0090","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0003-2697(86)90314-3","article-title":"Determination of cell number in monolayer cultures","volume":"159","author":"Gillies","year":"1986","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0095","article-title":"Autophagy in neurodegenerative diseases: pathogenesis and therapy","author":"Guo","year":"2017","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0100","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2011.200","article-title":"Control of autophagy as a therapy for neurodegenerative disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"598","key":"10.1016\/j.ijpharm.2018.04.032_b0105","article-title":"Resveratrol attenuates formaldehyde induced hyperphosphorylation of tau protein and cytotoxicity in N2a Cells","volume":"10","author":"He","year":"2017","journal-title":"Front. Neurosci."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.04.032_b0110","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jps.21952","article-title":"Preparation and physicochemical characterization of a novel water-soluble prodrug of carbamazepine","volume":"99","author":"Hemenway","year":"2009","journal-title":"J. Pharm. Sci."},{"issue":"5988","key":"10.1016\/j.ijpharm.2018.04.032_b0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1126\/science.1190354","article-title":"An autophagy-enhancing drug promotes degradation of mutant \u03b11-antitrypsin Z and reduces hepatic fibrosis","volume":"329","author":"Hidvegi","year":"2010","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.ijpharm.2018.04.032_b0120","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1002\/jps.24636","article-title":"Development of nutraceutical emulsions as risperidone delivery systems: characterization and toxicological studies","volume":"104","author":"Igart\u00faa","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0125","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijpharm.2010.04.027","article-title":"Dendrimer toxicity: let's meet the challenge","volume":"394","author":"Jain","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.04.032_b0130","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/00007691-200306000-00005","article-title":"Population pharmacokinetics of carbamazepine in Chinese epilepsy patients","volume":"25","author":"Jiao","year":"2003","journal-title":"Ther. Drug Monitor."},{"issue":"21","key":"10.1016\/j.ijpharm.2018.04.032_b0135","doi-asserted-by":"crossref","first-page":"8339","DOI":"10.1039\/c3cs60145e","article-title":"Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro\u2013in vivo gap","volume":"42","author":"Joris","year":"2013","journal-title":"Chem. Soc. Rev."},{"issue":"8","key":"10.1016\/j.ijpharm.2018.04.032_b0140","doi-asserted-by":"crossref","DOI":"10.1038\/s41570-017-0063","article-title":"Evolution of macromolecular complexity in drug delivery systems","volume":"1","author":"Kakkar","year":"2017","journal-title":"Nat. Rev. Chem."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0145","first-page":"1","article-title":"Dendrimers as tunable vectors of drug delivery systems and biomedical and ocular applications","volume":"11","author":"Kalomiraki","year":"2016","journal-title":"Int. J. Nanomed."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0150","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.progpolymsci.2013.07.005","article-title":"Dendrimer as nanocarrier for drug delivery","volume":"39","author":"Kesharwani","year":"2014","journal-title":"Prog. Polym. Sci."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0155","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0378-5173(99)00315-4","article-title":"Physicochemical properties and bioavailability of carbamazepine polymorphs and dihydrate","volume":"193","author":"Kobayashi","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0160","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0378-5173(03)00225-4","article-title":"Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers","volume":"259","author":"Kolhe","year":"2003","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0165","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/jcph.170","article-title":"Estimation and comparison of carbamazepine population pharmacokinetics using dried blood spot and plasma concentrations from people with epilepsy: the clinical implication","volume":"54","author":"Kong","year":"2014","journal-title":"J. Clin. Pharmacol."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0170","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/0003-2697(89)90710-0","article-title":"Quantification of cells cultured on 96-well plates","volume":"182","author":"Kueng","year":"1989","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.04.032_b0175","doi-asserted-by":"crossref","first-page":"433","DOI":"10.2174\/1567205011310040008","article-title":"Autophagy enhancer carbamazepine alleviates memory deficits and cerebral amyloid-\u03b2 pathology in a mouse model of Alzheimer's disease","volume":"10","author":"Li","year":"2013","journal-title":"Curr. Alzheimer Res."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.04.032_b0180","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/ma049168l","article-title":"Effect of solvent and pH on the structure of PAMAM dendrimers","volume":"38","author":"Maiti","year":"2005","journal-title":"Macromolecules"},{"issue":"16","key":"10.1016\/j.ijpharm.2018.04.032_b0185","doi-asserted-by":"crossref","first-page":"6236","DOI":"10.1021\/ma035629b","article-title":"Structure of PAMAM dendrimers: generations 1 through 11","volume":"37","author":"Maiti","year":"2004","journal-title":"Macromolecules"},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0190","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-3659(99)00246-1","article-title":"Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo","volume":"65","author":"Malik","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.04.032_b0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/B978-0-323-42866-8.00002-2","article-title":"Dendrimers in drug delivery","author":"Markowicz-Piasecka","year":"2016","journal-title":"Nanobiomater. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0200","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.powtec.2011.09.041","article-title":"Microstructured ternary solid dispersions to improve carbamazepine solubility","volume":"215","author":"Martins","year":"2012","journal-title":"Powder Technol."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0205","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2012.06.032","article-title":"Characterization and evaluation of solid self-microemulsifying drug delivery systems with porous carriers as systems for improved carbamazepine release","volume":"436","author":"Milovi\u0107","year":"2012","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijpharm.2018.04.032_b0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"issue":"3","key":"10.1016\/j.ijpharm.2018.04.032_b0215","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.taap.2010.08.016","article-title":"Mechanistic studies of in vitro cytotoxicity of poly (amidoamine) dendrimers in mammalian cells","volume":"248","author":"Mukherjee","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"29","key":"10.1016\/j.ijpharm.2018.04.032_b0220","doi-asserted-by":"crossref","first-page":"14198","DOI":"10.1021\/jp061311k","article-title":"Characterization by Fourier transform infrared spectroscopy (FT-IR) and 2D IR correlation spectroscopy of PAMAM dendrimer","volume":"110","author":"Popescu","year":"2006","journal-title":"J. Phys. Chem. B"},{"issue":"3","key":"10.1016\/j.ijpharm.2018.04.032_b0225","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1021\/mp8002489","article-title":"Dendimer-mediated solubilization, formulation development and in vitro\u2212 in vivo assessment of piroxicam","volume":"6","author":"Prajapati","year":"2009","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0230","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijpharm.2006.05.068","article-title":"Nanomolar cationic dendrimeric sulfadiazine as potential antitoxoplasmic agent","volume":"326","author":"Prieto","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0235","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijpharm.2008.04.045","article-title":"Brain and muscle of Wistar rats are the main targets of intravenous dendrimeric sulfadiazine","volume":"360","author":"Prieto","year":"2008","journal-title":"Int. J. Pharm."},{"issue":"121","key":"10.1016\/j.ijpharm.2018.04.032_b0240","article-title":"G4. 5 PAMAM dendrimer-risperidone: Biodistribution and behavioral changes in in vivo model","volume":"4","author":"Prieto","year":"2013","journal-title":"J. Nanomed. Biotherapeutic Discov."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0245","doi-asserted-by":"crossref","first-page":"e90393","DOI":"10.1371\/journal.pone.0090393","article-title":"Optimization and in vivo toxicity evaluation of G4. 5 PAMAM dendrimer-risperidone complexes","volume":"9","author":"Prieto","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.ijpharm.2018.04.032_b0250","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4236\/ojmc.2012.24016","article-title":"Effect of risperidone and fluoxetine on the movement and neurochemical changes of zebrafish","volume":"2","author":"Prieto","year":"2012","journal-title":"Open J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijpharm.2018.04.032_b0255","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ejmech.2010.12.021","article-title":"Optimization and in vitro toxicity evaluation of G4 PAMAM dendrimer\u2013risperidone complexes","volume":"46","author":"Prieto","year":"2011","journal-title":"Eur. J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijpharm.2018.04.032_b0260","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/clen.200900040","article-title":"Elimination of carbamazepine, diclofenac and naproxen from treated wastewater by nanofiltration","volume":"37","author":"R\u00f6hricht","year":"2009","journal-title":"CLEAN\u2013Soil Air Water"},{"key":"10.1016\/j.ijpharm.2018.04.032_b0265","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jconrel.2016.05.044","article-title":"Nanoparticle-mediated brain drug delivery: overcoming blood\u2013brain barrier to treat neurodegenerative diseases","volume":"235","author":"Saraiva","year":"2016","journal-title":"J. Control. Release"},{"issue":"Supplement C","key":"10.1016\/j.ijpharm.2018.04.032_b0270","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ntt.2013.01.003","article-title":"Assessment of the developmental neurotoxicity of compounds by measuring locomotor activity in zebrafish embryos and larvae","volume":"37","author":"Selderslaghs","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0275","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ejps.2014.04.019","article-title":"Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting","volume":"60","author":"Serralheiro","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"issue":"12","key":"10.1016\/j.ijpharm.2018.04.032_b0280","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1177\/106002809002401214","article-title":"A review of carbamazepine's hematologic reactions and monitoring recommendations","volume":"24","author":"Sobotka","year":"1990","journal-title":"DICP"},{"issue":"5","key":"10.1016\/j.ijpharm.2018.04.032_b0285","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000206413","article-title":"Carbamazepine-induced hemolytic anemia","volume":"72","author":"Stroink","year":"1984","journal-title":"Acta Haematol."},{"issue":"Supplement","key":"10.1016\/j.ijpharm.2018.04.032_b0290","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.addr.2012.09.030","article-title":"Dendrimers in biomedical applications\u2014reflections on the field","volume":"64","author":"Svenson","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.ijpharm.2018.04.032_b0295","doi-asserted-by":"crossref","first-page":"e0186194","DOI":"10.1371\/journal.pone.0186194","article-title":"Diacetylenic lipids in the design of stable lipopolymers able to complex and protect plasmid DNA","volume":"12","author":"Temprana","year":"2017","journal-title":"PLoS ONE"},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0300","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/anie.199001381","article-title":"Starburst dendrimers: Molecular-level control of size, shape, surface chemistry, topology, and flexibility from atoms to macroscopic matter","volume":"29","author":"Tomalia","year":"1990","journal-title":"Angew. Chem. Int. Ed."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0305","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/00007691-198703000-00020","article-title":"Minor additive inducing effects of phenobarbital on carbamazepine clearance in patients on combined carbamazepine-phenytoin therapy","volume":"9","author":"Tomson","year":"1987","journal-title":"Ther. Drug Monitor."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0310","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1351\/PAC-REC-10-12-04","article-title":"Terminology for biorelated polymers and applications (IUPAC Recommendations 2012)","volume":"84","author":"Vert","year":"2012","journal-title":"Pure Appl. Chem."},{"issue":"11","key":"10.1016\/j.ijpharm.2018.04.032_b0315","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.tips.2014.09.002","article-title":"Targeting autophagy in neurodegenerative diseases","volume":"35","author":"Vidal","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ijpharm.2018.04.032_b0320","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nchembio.79","article-title":"Novel targets for Huntington's disease in an mTOR-independent autophagy pathway","volume":"4","author":"Williams","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"10","key":"10.1016\/j.ijpharm.2018.04.032_b0325","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1016\/j.bmcl.2011.03.001","article-title":"Simultaneous DSC-FTIR microspectroscopy used to screen and detect the co-crystal formation in real time","volume":"21","author":"T-k","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.ijpharm.2018.04.032_b0330","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1532\/IJH97.07027","article-title":"Carbamazepine-induced hemolytic and aplastic crises associated with reduced glutathione peroxidase activity of erythrocytes","volume":"86","author":"Yamamoto","year":"2007","journal-title":"Int. J. Hematol."},{"issue":"1","key":"10.1016\/j.ijpharm.2018.04.032_b0335","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.toxlet.2014.05.009","article-title":"Uptake of silica nanoparticles: neurotoxicity and Alzheimer-like pathology in human SK-N-SH and mouse neuro2a neuroblastoma cells","volume":"229","author":"Yang","year":"2014","journal-title":"Toxicol. Lett."},{"issue":"2","key":"10.1016\/j.ijpharm.2018.04.032_b0340","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.yebeh.2007.10.015","article-title":"Erythrocyte and plasma fatty acid profiles in patients with epilepsy: does carbamazepine affect omega-3 fatty acid concentrations?","volume":"12","author":"Yuen","year":"2008","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0345","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.2147\/IJN.S106418","article-title":"The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells","volume":"11","author":"Zhang","year":"2016","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2018.04.032_b0350","first-page":"801","article-title":"Evaluating the effectiveness of GTM-1, rapamycin, and carbamazepine on autophagy and alzheimer disease","volume":"23","author":"Zhang","year":"2017","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318302497?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318302497?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T04:16:19Z","timestamp":1549080979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318302497"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0378517318302497"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.04.032","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: A biophysical and nanotoxicological characterization","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}